Back

Study on adverse clinical events in diabetic patients with glycemic control agents after acute myocardial infarction: japanese multicenter registry data

28 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Best Posters 7 - Best Posters in novelties in diabetes-associated coronary disease Treatment, Other ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Takayoshi Yamashita

Kumamoto University Hospital, Kumamoto (Japan)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor R. Fu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Doctor H. Jeong (Iksan, KR)
Abstract Slides
Presentation thumbnail
Doctor B. Berta (Kecskemet, HU)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 7 - Best Posters in novelties in diabetes-associated coronary disease

The Event

Event poster

ESC Congress 2018

28 August 2018 14:00 CET
You may be interested in
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI
26 May 2025
thumbnail
Congress Presentation
Hemoglobin glycation index and in-hospital mortality after acute myocardial infarction in patients with/without diabetes: a prospective, nationwide, and multicenter registry
31 August 2025
thumbnail
Congress Presentation
Diabetes in patients with heart failure: a frequent and dangerous association. A report from OFFICE IC AR registry
29 June 2021
thumbnail
Congress Presentation
Treatment with SGLT2 inhibitors in the early phase post acute myocardial infarction
15 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources